Sign in

CIK 0001723128

  • Large accelerated filer

Amneal Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
Phone
+1 908-947-3120
Former names
Atlas Holdings, Inc.
  1. 4 Exercise or conversion Director acquired 6,459 shares (option exercise)
  2. 4 Exercise or conversion Director acquired 6,459 shares (option exercise)
  3. 4 Exercise or conversion Director acquired 6,459 shares (option exercise)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Exercise or conversion Director acquired 6,459 shares (option exercise)
  9. 4 Open-market buy Director bought 353,649 shares at an average $2.74 ($970,344)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market buy Co-CEO and Director bought 100,000 shares at $3.09 ($309,000)
  13. 4 Open-market buy President, Co-CEO & Director bought 100,000 shares at $3.09 ($309,000)
  14. 4 Open-market buy President, Co-CEO & Director bought 250,000 shares at an average $3.90 ($974,958)
  15. 4 Open-market buy Director bought 150,000 shares at an average $3.93 ($589,073)
  16. 4 Open-market buy Co-CEO and Director bought 250,000 shares at an average $3.90 ($974,942)
  17. 4 Shares withheld for taxes SVP, Chief HR Officer gave up 4,228 shares (to pay taxes)
  18. 4 Shares withheld for taxes Exec VP, Comm Optns gave up 6,683 shares (to pay taxes)
  19. 4 Open-market buy SVP, Specialty Commercial bought 40,000 shares at $3.62 ($144,800)
  20. 4 Derivatives Options or other derivatives

Page 12 of 18 · 351 filings